Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 201-250 of 1147 result(s).
CYDY CytoDyn Inc
05/08/2025 1:31:19 AM
Jan 13, 2020 -- CytoDyn Files for B (4)
CYDY CytoDyn Inc
05/08/2025 1:15:57 AM
End ?..not 100% but cut the odds si (2)
CYDY CytoDyn Inc
05/08/2025 12:49:10 AM
Is this an overlooked positive ? Ho (6)
CYDY CytoDyn Inc
05/07/2025 7:20:54 PM
Trovedly was approved on it likely (2)
CYDY CytoDyn Inc
05/07/2025 6:26:34 PM
Cytodyn --- you're eager to share M (5)
CYDY CytoDyn Inc
05/07/2025 6:18:19 PM
Now FDA / EU give us temp approval (8)
CYDY CytoDyn Inc
05/07/2025 6:06:48 PM
Dr. Sacha started with CRISPR, swit (6)
CYDY CytoDyn Inc
05/07/2025 1:18:26 PM
Clarity on the MOA, with a real gam (2)
CYDY CytoDyn Inc
05/07/2025 12:14:11 PM
"HODL!"...Relevant?? Naw, i think t
CYDY CytoDyn Inc
05/07/2025 7:54:27 AM
Jake22 --- you are overlooking some (4)
CYDY CytoDyn Inc
05/07/2025 7:34:58 AM
You're right about the Dec - March (5)
CYDY CytoDyn Inc
05/06/2025 9:16:11 PM
From our new CFO profile CombiMatri (4)
CYDY CytoDyn Inc
05/06/2025 8:47:13 PM
Colorectal cancer, approximately 70 (6)
CYDY CytoDyn Inc
05/06/2025 9:58:00 AM
".....and was an advisor to the Fin (4)
CYDY CytoDyn Inc
05/05/2025 6:38:22 PM
Dr. Ari D. Baron @ BGT's colorectal (7)
CYDY CytoDyn Inc
05/04/2025 10:57:40 PM
Dr. Rui holds the position of Profe (5)
CYDY CytoDyn Inc
05/04/2025 7:58:06 PM
Just like the shares in your tight (2)
CYDY CytoDyn Inc
05/04/2025 10:57:38 AM
If this does not, FDA mite as well (4)
CYDY CytoDyn Inc
05/04/2025 8:34:26 AM
Thx jeff -- it's similar to canada' (1)
CYDY CytoDyn Inc
05/04/2025 8:32:53 AM
Dec. 2024, 36+/48+ & ESMO off-site (4)
CYDY CytoDyn Inc
05/04/2025 8:07:43 AM
Wish i wrote as clear as you & othe (1)
CYDY CytoDyn Inc
05/04/2025 8:03:01 AM
Invite, talk about LL /LL-PLS & MOA (5)
CYDY CytoDyn Inc
05/04/2025 7:46:26 AM
KC -- check this out: ESMO's other (12)
CYDY CytoDyn Inc
05/03/2025 8:35:27 PM
Look @ ESMO from KOL perspective. T (19)
CYDY CytoDyn Inc
05/02/2025 10:51:55 PM
Nov 16, 2021 -- Health Canada Autho (5)
CYDY CytoDyn Inc
05/02/2025 2:53:01 AM
From NASH patent application publis (7)
CYDY CytoDyn Inc
05/01/2025 8:48:24 AM
Leronlimab can/will create a new cl (5)
CYDY CytoDyn Inc
04/30/2025 11:22:09 PM
Now re-read Roza's discovery for Le (2)
CYDY CytoDyn Inc
04/30/2025 11:07:29 PM
2 hrs ago. The US Food and Drug Adm (3)
CYDY CytoDyn Inc
04/30/2025 10:03:19 PM
March letter & Follow-up: In the me (7)
CYDY CytoDyn Inc
04/30/2025 8:25:01 PM
Rough patient estimate: More than 4 (4)
CYDY CytoDyn Inc
04/30/2025 6:33:17 AM
Thank you Roza Ogurlu !! Presentati (6)
CYDY CytoDyn Inc
04/30/2025 1:29:41 AM
"This means that, on average, half (6)
CYDY CytoDyn Inc
04/29/2025 9:33:23 PM
July 2024 settlement. Today Cytodyn (2)
CYDY CytoDyn Inc
04/29/2025 8:28:57 PM
I would keep an eye on the BOD. Fro (3)
CYDY CytoDyn Inc
04/29/2025 6:23:40 PM
Safety hold -- how about a clawback (4)
CYDY CytoDyn Inc
04/29/2025 5:25:55 PM
and....not as
CYDY CytoDyn Inc
04/29/2025 5:25:27 PM
Think you're right --- only Dr. J a (1)
CYDY CytoDyn Inc
04/29/2025 4:10:43 PM
Gilead $200m fine is exactly what n (6)
CYDY CytoDyn Inc
04/29/2025 3:40:18 PM
Gilrad....caught crooked Hiv hand h (3)
CYDY CytoDyn Inc
04/29/2025 11:34:02 AM
Expecting FDA path to approval news (5)
CYDY CytoDyn Inc
04/29/2025 9:18:50 AM
& on that...with 12 month increment (2)
CYDY CytoDyn Inc
04/29/2025 8:38:55 AM
A second group ?? --" more than 48 (4)
CYDY CytoDyn Inc
04/27/2025 9:19:28 PM
Keep in mind Cytodyn is not the fun (4)
CYDY CytoDyn Inc
04/27/2025 9:14:57 PM
The Hiv-PLS is a joint collaboratio (1)
CYDY CytoDyn Inc
04/27/2025 5:45:49 PM
Why present Hiv FcRn now @ 1 year o (4)
CYDY CytoDyn Inc
04/27/2025 10:38:31 AM
May 15th: 1. We own all trial data. (6)
CYDY CytoDyn Inc
04/25/2025 9:15:37 PM
Project End Date 30-June-2025. " Su (6)
CYDY CytoDyn Inc
04/25/2025 11:22:43 AM
No SAE's. No drug - drug. No trial (5)
CYDY CytoDyn Inc
04/24/2025 10:50:03 AM
Each year, ESMO brings together ove (3)
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • Celebrating the Success of 'Tiantan Award Panorama' in Sydney
  • Asset Reality Gains FCA Approval for Crypto Custody Solutions
  • Understanding the Auction Process for Riksbank Certificates
  • Virtune Expands Crypto Investment Options with ETP Launch
  • Understanding the Disclosure Process in Share Trading
  • Allego Strengthens Leadership with New Innovative CTO
  • Baidu's New CFO: Steering Innovation Amidst U.S. Challenges
  • Transforming Healthcare with Microsoft's Revolutionary AI System
  • James Chanos Critiques Michael Saylor's Valuation Approach
  • Hikvision's New Bullet Cameras Redefine Perimeter Security
  • Honoring Björn Nykvist: Pioneering Research in Transportation
  • Kia America Sets New Sales Record in First Half of 2025
  • Virtune Launches VCOIN50 ETP on Euronext, Expanding Access
  • Municipality Finance Raises EUR 40 Million with New Zero Coupon Notes
  • Joseph Shipley Joins FTI Consulting to Enhance Private Equity Focus
  • Shift in Trade Policy: U.S. Adjusts Plans Amid Tariff Pressures
  • Tom Lee Advocates Ethereum Integration with Banking Sector
  • S&P 500: Analyzing Market Signals Amid Economic Changes
  • Major Shareholder Update from Tivoli A/S: Key Changes
  • Important Suspension Announcement from Danske Invest Fund Group
  • AI Prime and Barclays Bank's Accelerated Share Placing Details
  • Tivoli A/S Announces Managerial Transactions and Insights
  • Mike Pence's Advocacy Group Promotes Continuation of Tax Cuts
  • Exploring OpenInfra Summit: A Hub for Open Source Innovation
  • Sumsub's AML Monitoring Delivers Impressive 272% ROI for Businesses
  • Hemispherian's GLIX1 Gains Orphan Drug Designation for Cancer
  • Revolutionizing Road Safety: AI Crash Probability Hub Launch
  • Explore Arkay's Alcohol-Free Whisky for Modern Living
  • JDE Peet's New Strategy Aims for Profitable Growth and Value
  • Aegon Initiates EUR 200 Million Share Buyback Program
  • Regents Gate Capital Enhances Trading with big xyt's Analytics
  • Investor Optimism Prevails Amidst Sluggish Economic Growth
  • ISS Group Partners with VELUX for Enhanced Facility Services
  • Allego Welcomes Holger Riemenschneider as New CTO
  • Rinri Therapeutics Advances Hearing Loss Therapy with UK Trial Launch
  • Updates on Wealth Invest: Key Changes in Investment Areas
  • Municipality Finance Raises EUR 40 Million with Zero Coupon Notes
  • Updated Investment Profiles: Maj Invest Enhances Offerings
  • FTI Consulting Welcomes Joseph Shipley to Drive Private Equity Efforts
  • Ignitis Group Advances Renewable Energy with New Projects
  • Understanding PayPoint Plc's Total Voting Rights and Capital
  • Atos Group Faces Jury Verdict in TriZetto Litigation Case
  • Equinor ASA Updates on Second Share Buy-back Tranche
  • Understanding Voting Rights in Share Capital Management
  • INVL Asset Management Secures EUR 35.43 Million for Growth
  • Exploring AI's Role in Enhancing Sports Fan Experience Today
  • Leadership Transition at Apranga Group: CFO Appointment News
  • Insights into Jyske Realkredit's Cash Flow Announcements
  • Coinbase's Legal Team Promises to Uphold User Privacy Rights
  • Join Ericsson's Q2 2025 Briefing and Discover Key Insights
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site